Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs-Reference-Cited by-同舟云学术

Direct-acting antiviral drug approvals for treatment of chronic hepatitis C virus infection: Scientific and regulatory approaches to clinical trial designs

Published:2015-06-19 Issue:4 Volume:62 Page:1298-1303
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mishra Poonam¹,Murray Jeffrey¹,Birnkrant Debra¹

Affiliation:

1. Division of Antiviral Products/Office of Antimicrobial Products; Center for Drug Evaluation and Research; U.S. Food and Drug Administration; Silver Spring MD

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27880/fullpdf

Reference25 articles.

1. American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

2. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011

3. http://www.hcvguidelines.org

4. ® http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/202258s014lbl.pdf

5. ® http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201917s012lbl.pdf

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis;Drug Safety;2020-11-03

2. Simplification of Care for Chronic Hepatitis C Virus Infection;Seminars in Liver Disease;2020-07-28

3. Development of a Method for Screening and Genotyping of HCV 1a, 1b, 2, 3, 4, and 6 Genotypes;ACS Omega;2020-05-08

4. B.A.R.C.O.S. (Brazilian Argentine Hepatitis C Collaborative Observational Study): Effectiveness and clinical outcomes of HCV treatment with daclatasvir and sofosbuvir with or without ribavirin;Journal of Viral Hepatitis;2019-06-19

5. Valor terapéutico y precio de los nuevos fármacos comercializados en Argentina: ¿valen lo que cuestan?;Salud Colectiva;2019-03-10